ArticleJournal for immunotherapy of cancer2026

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T.

Ning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.